Procter & Gamble is an American company which engages in the provision of branded consumer packaged goods, operating through segments namely Beauty, Grooming, Health Care, Fabric and Home Care, Baby, Feminine and Family Care. The company shall release its earnings result for the fiscal quarter ending March 2023 on 21st April (Friday), before market open.
Fig.1: Reported Sales of P&G versus Analyst Forecast. Source： CNN Business
Throughout the decade (2012-2022), the company recorded the lowest sales in 2017, which was $65.1B. However, its sales gradually recovered for the next five years, to $80B in 2022, up over 23%. The company’s success as “the maker of everything you buy for your house” is inseparable from a good business strategy, which includes understanding consumer needs, strong research and development, marketing, diversification and brand positioning.
In addition, P&G recently announced a 3% dividend hike, to $94.07/share. This marks the company’s 67th consecutive year of dividend hikes. Its ability to pay dividends for over a century in the past reflected the company’s solid fundamentals and financial strength, including a strong cash flow generation capability.
In the coming earnings announcement, consensus estimates for sales of P&G stood at $19.2B, down -7.69% from the previous quarter and slightly below the same period last year which was recorded at $19.4B.
Fig.2: Reported EPS of P&G versus Analyst Forecast. Source: ：CNN Business
EPS wise, the figure hit $5.81 in FY 2022. Market consensus for EPS in the coming quarter stood at $1.32, down nearly -17% from the previous quarter, and remains flat as the same period last year. In general, market participants do not anticipate growth nor losses throughout the year, in which sales and EPS were forecast to remain flat at $80.8B and $5.83, respectively.
#Procter&Gamble (PG.s), Daily: The share price underwent three different phases during the first quarter this year. It started with a downtrend in January, leaving the year high at $154.79. It hit a bottom in February, remaining consolidated at the low range $135.81-$141.57. It then rode on a strong bullish wave and recouped over 90% of January’s losses, and is currently above support $148.55 (FR 61.8%). The high of this month $152.91 serves as minor resistance. A break above this level may encourage the bulls to continue testing zone $154.79-$156, followed by psychological level $160. On the other hand, if price breaks below $148.55, it may dive lower to test dynamic support 100-day SMA, followed by $143.50 (FR 50.0%). Price closure below these two critical levels may indicate bearish continuation.
Click here to access our Economic Calendar
Disclaimer: This material is provided as a general marketing communication for information purposes only and does not constitute an independent investment research. Nothing in this communication contains, or should be considered as containing, an investment advice or an investment recommendation or a solicitation for the purpose of buying or selling of any financial instrument. All information provided is gathered from reputable sources and any information containing an indication of past performance is not a guarantee or reliable indicator of future performance. Users acknowledge that any investment in Leveraged Products is characterized by a certain degree of uncertainty and that any investment of this nature involves a high level of risk for which the users are solely responsible and liable. We assume no liability for any loss arising from any investment made based on the information provided in this communication. This communication must not be reproduced or further distributed without our prior written permission.